Head-to-head · WeighScore
Science & Co vs SexyMD
By GLP-1 ScorecardUpdated
Score comparison
Science & Co has the higher recorded score — 72.9/100 to 60.3/100.
Science & Co grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. States in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two things almost nothing else here does.
Before you choose
Before comparing the headline prices, the Science & Co review and the SexyMD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Science & Co vs Trellis Vitality and SexyMD vs The Edit compare each of them with another graded program, and the list of alternatives to Science & Co ranks the programs closest to Science & Co on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Science & Co | SexyMD |
|---|---|---|
| WeighScore | 72.9/100 | 60.3/100 |
| Grade | C | C |
| Site position | #82 | #354 |
| Semaglutide | $149/mo month-to-month ($79 only on a 12-month plan) | $149/mo (4-week plan; $99/mo on 48-week plan; compounded) |
| Tirzepatide | $199/mo month-to-month ($125 only on a 12-month plan) | $199/mo (4-week plan; $129/mo on 48-week plan; compounded) |
| Coverage | Not publicly listed | 47 states (all except Arkansas, Mississippi and New Jersey) |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
- Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
- The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
- "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
- Names its operating entity and state of incorporation, and says every batch is third-party tested
What to consider
- The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
- It says it is not a compounding facility but never names the pharmacy that is
- No lab or monitoring protocol is published
- Injection only on the pages read — no oral route and no brand lane
Strengths
- Publishes an exact exclusion list — all states except Arkansas, Mississippi and New Jersey — rather than a nationwide claim
- States both compounding classes in the Terms, so the class question is answered even though the pharmacy is not named
- Names the prescribing entity and the professional corporation behind it
- Sells two microdose products with their own published price tables rather than only as a discount tier
What to consider
- Every headline price is the 48-week commitment rate: $99 against a four-week figure of $149, and $129 against $199, with an asterisk that resolves to no footnote
- The same footer, on every page, says both that the service is available in all 50 states and that it is available in all states except three
- The two microdose products publish identical prices for their 4-, 8- and 12-week plans, in the same table format that carries real tiers elsewhere
- The microdose page contradicts itself on dosing frequency inside a single page
- Three unsourced and mutually inconsistent social-proof figures appear across the homepage, the footer and the product pages
- The checkout claims two patient counts for a single day that together exceed the total the site's own badge claims
- No pharmacy is named, and what the price includes is never itemized on any product page
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.